12 Health Care Stocks Moving In Tuesday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Tuesday's after-market session, several healthcare stocks experienced significant movements. Phio Pharma (PHIO) saw a 19.6% increase, while Lucy Scientific Discovery (LSDI) rose by 9.34%. Aclaris Therapeutics (ACRS) went up by 8.47%, and Minerva Surgical (UTRS) by 8.36%. Pasithea Therapeutics (KTTA) and Phreesia (PHR) also saw gains of 6.77% and 5.76%, respectively. On the downside, Allarity Therapeutics (ALLR) dropped by 8.1%, InVivo Therapeutics (NVIV) by 7.06%, Longeveron (LGVN) by 6.2%, Surrozen (SRZN) by 6.01%, Impel Pharmaceuticals (IMPL) by 5.58%, and BioCardia (BCDA) by 5.49%.
December 05, 2023 | 9:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Allarity Therapeutics' stock decreased by 8.1% to $0.53, with a market cap of $2.4 million.
The decline in Allarity Therapeutics' stock price could suggest a negative short-term outlook, potentially due to investor concerns.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
BioCardia's shares decreased by 5.49% to $0.62, with a market cap of $14.6 million.
BioCardia's stock price decline in the after-market session could suggest a bearish short-term trajectory.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Impel Pharmaceuticals' stock fell by 5.58% to $0.44, with a market cap of $10.5 million.
The drop in Impel Pharmaceuticals' share price may continue short term, reflecting negative market sentiment.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Longeveron's shares dropped by 6.2% to $2.0, with a market cap of $47.4 million.
The decrease in Longeveron's stock price may reflect a short-term negative trend if the market continues to react unfavorably.
CONFIDENCE 90
IMPORTANCE 65
RELEVANCE 100
NEGATIVE IMPACT
InVivo Therapeutics' shares fell by 7.06% to $0.79, with a market cap of $2.4 million.
InVivo Therapeutics' after-market decline could continue into the short term if the negative sentiment persists.
CONFIDENCE 90
IMPORTANCE 65
RELEVANCE 100
NEGATIVE IMPACT
Surrozen's stock went down by 6.01% to $0.5, with a market cap of $15.3 million.
Surrozen's after-market stock decline could indicate a bearish short-term outlook if the selling pressure continues.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
Aclaris Therapeutics' stock rose by 8.47% to $1.07, with a market cap of $75.7 million.
Aclaris Therapeutics' after-market increase could be a positive signal for short-term price movement, especially if the market responds well to their Q3 earnings.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Pasithea Therapeutics' stock increased by 6.77% to $0.32, with a market cap of $6.5 million.
The gain in Pasithea Therapeutics' shares could indicate a positive short-term trend if the market momentum continues.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
Lucy Scientific Discovery's shares increased by 9.34% to $0.33, with a market cap of $5.8 million.
The after-market rise in Lucy Scientific Discovery's stock price could attract more attention to the stock, potentially leading to further short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Phio Pharma's stock surged 19.6% to $1.34 with a market cap of $3.2 million.
The significant after-market gain for Phio Pharma suggests positive investor sentiment, which could lead to a short-term continuation of this upward trend.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Phreesia's stock rose by 5.76% to $15.6, with a market cap of $861.2 million, following their Q3 earnings release.
Phreesia's stock increase after their Q3 earnings could lead to a positive short-term impact if the earnings are well-received by the market.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100
POSITIVE IMPACT
Minerva Surgical's stock climbed 8.36% to $2.85, with a market cap of $25.3 million.
The upward movement for Minerva Surgical may continue in the short term, given the positive after-market performance.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100